SU1016314A1 - Process for producing polyester urethanes - Google Patents
Process for producing polyester urethanes Download PDFInfo
- Publication number
- SU1016314A1 SU1016314A1 SU792854648A SU2854648A SU1016314A1 SU 1016314 A1 SU1016314 A1 SU 1016314A1 SU 792854648 A SU792854648 A SU 792854648A SU 2854648 A SU2854648 A SU 2854648A SU 1016314 A1 SU1016314 A1 SU 1016314A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- hydroxyl
- melt
- oligomer
- diol
- producing polyester
- Prior art date
Links
Landscapes
- Polyurethanes Or Polyureas (AREA)
Abstract
СПОСОБ ПОЛУЧЕНИЯ ПОЛИЭФИРУРЕТАНрВ путем взаимодействи в . (расплаве сложного гидроксилсодержащего блигоэфира с гексаметилендиизоцианатом в присутствии диола, от- i личающийс тем, что, с целью придани конечному продукту биодеградируемых свойств, в качестве сложного гидроксилсодержащего олигоэфира используют соединение общей формулы pf-f 0-сн-со ) со-сн-О ti н, где с 0-20; Е 0-20 (причемЛ 0, t О, , 1. 0); R-Mi CHjилиК р-Н, или R R-CH5V. CHv § -№)2r{ l«2i3 , СИ, Ч ca2)(CH2-o-iMETHOD OF OBTAINING POLYESTERURATANANV through interaction c. (a melt of a hydroxyl-containing glycosyl ester with hexamethylene diisocyanate in the presence of a diol, characterized in that, in order to impart biodegradable properties to the final product, a hydroxyl-containing oligoester is used as a hydroxyl-containing oligoester with a compound of the general formula pf-f 0-ch-co) co-ch-O ti n, where c 0-20; E 0-20 (where L 0, t О,, 1. 0); R-Mi CHjiliK rn, or R R-CH5V. CHv § -№) 2r {l «2i3, SI, H ca2) (CH2-o-i
Description
Изобретение относитс к синтезу полйэфируретанов, которые могут быть использованы в медицине, например, ; в качестве саморассасьшанмдихс хирур гических материалов. Известен способ получени полиэфи уретанов путем взаимодействи гидроксцлсодержащих олигомеров сложноэфирного- , типа с диизоцианатом в присутствии диола l3. Недостатком известного рпособа получени полйэфируретанов йвл етс их непригодность дл использовани в медицине в качестве биодеградируемых материалов Наиболее близкий по технической сущности к предлагаемому вл етс способ получеин полйэфируретанов путем взаимодействи в расплаве слож ного гидроксилсодержащего олигоэФира с гексаметилендиизоцианатом в при- , сутствии диола. В качестве сложного гидроксилсоЬёржащего олигоэФира используют продукт конденсации дикарбоновой кислот и диола, например адипиновой кислоты и этиленгликол в расплаве С2. Недостатком, полученных известным способом,.полйэфируретанов вл етс отсутствие в нх макромолекулах св зей , способных подвергатьс ферментативной биодеградации. Целью изобретени вл етс придание биодеградируемых свойств конечному продукту. Указанна цель достигаетс тем, что согласно способу при получении полйэфируретанов путем взаимодействи в расплаве сложного гидроксилсодер ащего олигоэФира используют соедиени формулы RК II Jlf (Jfl СО-(Н- О -)- Н, де Ч 0-20 0-20 (причем 1с О, С О, ) е О, 1 О R--H R--CHj или R-R-H , или Р Р--СНэ, , .СНз R- - 1 5Н21г rl iHjts , (jHj iCH2)2-iH-,-(SH2)f-0-( и процесс провод т ступенчато: при 90-120с в течение 0,5-1 ч, при 160190°С в течение 4-5 ч. Блоксополимерную структуру полученных полимеров подтверждают изучением их растворимости в органических растворител х и сравнением с растворимостью соответствующих гомополимеров , а также изучением их ИК- и ЯМР-спектров. синтезированные полиэФируретаны облгщают пленко- и волокнообразующими свойствами- Они раствор ютс во многих органических раст ворител х, образу высококонцентрированные растворы, из этих раствором методом полива на стекл нные подложки были получены эластичные пленки, имеющие прочность на разрыв 300400 кг/см2 и разрывное удлинение 100200% . Строение и характеристики испольгюванных полиэфирных смол привод тс . в табл.1. Т а б л и ц а 1This invention relates to the synthesis of polyether urethanes that can be used in medicine, for example; as a samorasshansmidkhs surgical materials. A known method of producing polyether urethanes by reacting hydroxyl-containing oligomers of an ester- type, with a diisocyanate in the presence of a diol l3. A disadvantage of the known method of producing polyether urethanes is their unsuitability for use in medicine as biodegradable materials. The most similar in technical essence to the proposed method is the method of obtaining polyether urethanes by melting complex hydroxyl-containing oligophira with the hexamethyleni-iso-isocyanate iannidar i'm i'm i'm io4 i4i4i4i4i-4y; As a complex hydroxyl-bearing oligo-efir, a condensation product of dicarboxylic acids and a diol, for example, adipic acid and ethylene glycol in the C2 melt, is used. A disadvantage obtained in a known manner, polyetheruretans, is the absence of bonds in their macromolecules capable of undergoing enzymatic biodegradation. The aim of the invention is to impart biodegradable properties to the final product. This goal is achieved by the fact that, according to the method for obtaining polyetheruretans, by using a compound of the formula RK II Jlf (Jfl CO- (H - O -) - H, de H 0-20 0-20 (1C O , С О,) е О, 1 О R - H R - CHj or RRH, or Р Р - СНэ,, .СНз R- - 1 5Н21г rl iHjts, (jHj iCH2) 2-iH -, - ( SH2) f-0- (and the process is carried out in steps: at 90-120 s for 0.5-1 h, at 160190 ° C for 4-5 h. The block-polymer structure of the obtained polymers is confirmed by studying their solubility in organic solvents and by comparison with solubility with the corresponding homopolymers, as well as the study of their IR and NMR spectra. The synthesized polyfiruretans exhibit film- and fiber-forming properties. They dissolve in many organic diluents, forming highly concentrated solutions, and elastic films were obtained from these solutions by pouring onto glass substrates. having a tensile strength of 300,400 kg / cm2 and a tensile elongation of 100,200%. The structure and characteristics of used polyester resins are given. in table.1. Table 1
Пример 1.В трехгорлую , снабженную мешалкой, вводом и выводом дл аргона помещают 0,005 моль олигомера СЭ-1-0 (табл.1) и колбу нагревают до 120-125°С. К образовавшемус расплаву добавл ют половину (0,05 моль) гексаметилендиизоцианата (суммарное количество гексаметилендиизоцианата 0,1 моль). Расплав перемешивают в течение 30 мин, после .чеГО температуру снижают до 90-10Ь°С и ввод т Qf095 моль удлинител (диола )S 1,3-пропандиола. Смесь вновь .нагребают до и перемешивают еще 30 мий к затем осторожно, по пор ) ди м ввод т оставше ес количество (0,05 моль дииэоцианата). Реакционна масра быстро загустевает и не переме шиваетс . Температуру медленно повышают до так, чтобы реакционна смесь легко пе ремешивалась и выдержи Ьают при данной температуре в течени 4 ч Расплав выливают на чашку Петри и охлаждают. Приведенна в зкость 0,64 д-л/г в м-крезоле, t 2УС, С в 0,5 г/дл. . Пример 2. В трехгорлую Колбу , снабженную мешалкой, вводоми выводом дл аргона помещают 0,0в5 мо олигомёра СЭ-06-04, колбу нагревают до 9Q°C и к образоваввюмус расплаву добавл ют половину 0,05 моль гексаметилендиизоцианата . Реакционную смеЪь нагревают до в течение 30 мин затем охлаждают до 90°С и ввод т 0, моль пропандиола, вновь нагревают ДО 120°С в течение 30 миН охлаждают до 90°е и осторожно ввод т оставшеес количество диизоцианата. Смесь медленно нагревают до 1бО°С, причем теютературу повышают так, чтобы в колбе был хорошо перемешиваеквдй расплав. Реакционную смесь: вы держивают при в течение 5 ч,, после чеговыливают на чашку Петри н охлаждают. Чпр 0,58 дл/г в смеси тетрахлорзтан: фенол (3:1), t° 25с, С 0,5 г/дл. Пример 3. Синтез полимера осуществл ют в соответствии с методикой , приведенной в. примере 2, с той лишь разницей, что вместо олиго-, мера СЭ-Об-04 (табл.) используют олигомер СЭ-05-05 (табл.1), а вкачестве удлинител цепи вместо.1,3пропандиола используют зтиленгликольц 0,52 дл/г в смеси тетрахлорт зтан: енол (3:1), t 25«с, С 0,5 г/дл. Пример 4. Синтез полимера осуществл ют в соответствии с методикой приведенной в примере 2, с той разницей, что вместо оп гомера СЭ-06-04; берут олигомер СЭ-05-05, . 0,5d дл/г в смеси тетрёиелорэтана с фенолом 3:l,t° 25°С, С 0,5 г/дл,, П р и м е р 5. Синтез полимера осуществл ют в соответствии с методикой , приведенной впримере 2 с -той разницей, что вместо олигомёра СЭ-06-04 берут олигомер СЭ-04-05, «Injp 0,4 дл/г в смеси тетрахлорэтана С фенолом 3:1, t , С 0,5 г/дл. Пример 6. СийЧгез полимера осуществл ют в соответствии с методикой , приведенной в примере 2, с той разницей, что вместо олигомёра СЭ-06-04 берут олигомер СЭ-0-1 , - 0,48 дл/г в смеси твтргослорэтана с фенолом (3:1), t® 25°С, С 0,5 г/дл. Пример 7. Синтез пЬлимера осу1цествл 1от в соответствии с методикой , приведенной в примере 1, с той разницей, что вместо олигомёра СЭ-1-0 беруt олигомер СП-1-0 (табл.1) H«p 0,60 дл/г в м-крезоле, , С 0,5 г/дл. Услови синтеза и основные характеристики полученнш полиэфируретанов приведены в табл.2.Example 1. In a three-necked, equipped with a stirrer, the input and output for argon is placed 0.005 mol of oligomer SE-1-0 (table 1) and the flask is heated to 120-125 ° C. To the resulting melt, half (0.05 mol) of hexamethylene diisocyanate is added (the total amount of hexamethylene diisocyanate is 0.1 mol). The melt is stirred for 30 minutes, after which the temperature is lowered to 90-10 ° C and Qf095 mol of the extender (diol) S 1,3-propanediol is introduced. The mixture is refilled again and stirred for another 30 missions, then carefully, at times, the remaining amount (0.05 mol of di-isocyanate) is added. The reaction mixture thickens rapidly and is not stirred. The temperature is slowly raised until the reaction mixture is easily stirred and kept at this temperature for 4 hours. The melt is poured onto a Petri dish and cooled. The reduced viscosity is 0.64 dl / g in m-cresol, t 2US, С at 0.5 g / dL. . Example 2. In a three-necked flask equipped with a stirrer, an inlet for argon was placed with 0.0–5 mo of SE-06-04 oligomer, the flask was heated to 9Q ° C, and half of 0.05 mole of hexamethylene diisocyanate was added to the melt. The reaction mixture is heated to 30 minutes, then cooled to 90 ° C and 0 mol of propane diol is introduced, heated to 120 ° C again for 30 min to 90 ° C and the remaining amount of diisocyanate is carefully added. The mixture is slowly heated to 1 ° C, and the temperature is increased so that the flask has a well mixed melt. The reaction mixture: you are kept at for 5 h after it is poured onto a Petri dish and cooled. Chpr 0,58 dl / g in a mixture of tetrachlorotane: phenol (3: 1), t ° 25s, With 0.5 g / dl. Example 3. Synthesis of the polymer was carried out in accordance with the procedure given in c. Example 2, with the only difference that instead of oligo-, measure СЭ-Об-04 (table), use oligomer СЭ-05-05 (table 1), and as a chain extender instead of 1.3 propandiol use ethylene glycol 0.52 dl / g in a mixture of tetrachloride ztan: enol (3: 1), t 25 "s, C 0.5 g / dl. Example 4. Synthesis of the polymer was carried out in accordance with the procedure described in example 2, with the difference that instead of the opomer SE-06-04; take oligomer SE-05-05,. 0.5d dl / g in a mixture of tetroyelorethan with phenol 3: l, t ° 25 ° C, 0.5 g / dL, Example 5 Polymer synthesis is carried out in accordance with the procedure given in Example 2 with the difference that instead of an oligomer of SE-06-04 an oligomer of SE-04-05 is taken, “Injp 0.4 dl / g in a mixture of tetrachloroethane With phenol 3: 1, t, C 0.5 g / dl. EXAMPLE 6 Polymer Synthesis was carried out in accordance with the procedure described in Example 2, with the difference that instead of the SE-06-04 oligomer, the SE-0-1 oligomer was taken to be 0.48 dl / g in a mixture of tvtssloroethane and phenol ( 3: 1), t® 25 ° С, С 0.5 g / dl. Example 7. Synthesis of catalyst size is 1 according to the procedure described in example 1, with the difference that instead of oligomer СЭ-1-0 take SP-1-0 oligomer (Table 1) H «p 0.60 dl / g in m-cresol, C 0.5 g / dl. The synthesis conditions and the main characteristics of the polyether urethanes obtained are given in Table 2.
Таким образом, п менение предлагаемого способа получени полиэфируретанов , содержащих в цеп х макромолекул олигоэфирные блоки на осиове ici-оксикислот Обеспечивает следук цие преимущества: использование в качестве исходных смол олигоэфиров на основе Ыгоксикислот позвол ет получать полиэфируретаны содержгицие в цеп х макро{молекул о6 дфнрные св зи способны под--, вергатьс ферментативной биодегргц1ацииThus, the proposed method of producing polyether urethanes containing oligoester blocks on the chain of ici-hydroxy acids in the chains of macromolecules provides the following advantages: using polyhydric esters based on polyhydroxy esters as the starting resin allows zi capable of underwater fermentation biodegradation
полученные полизфируретаны полезны дл 11спользованн в медицине в качестве саморассасывающихс материалов , поскольку содержат в цеп х макромолекул биодеградируемые cL-зфирные св зи;The resulting polyesterutanes are useful in medicine as self-absorbing materials, since they contain biodegradable cl-spherical bonds in the chains of macromolecules;
растворимость полученных полиэфируретанов в органических растворител х , что облегчает их переработку в издели -пленки, пористые материалы и т.д.the solubility of the obtained polyether urethane in organic solvents, which facilitates their processing into articles - films, porous materials, etc.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU792854648A SU1016314A1 (en) | 1979-12-17 | 1979-12-17 | Process for producing polyester urethanes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU792854648A SU1016314A1 (en) | 1979-12-17 | 1979-12-17 | Process for producing polyester urethanes |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1016314A1 true SU1016314A1 (en) | 1983-05-07 |
Family
ID=20865692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU792854648A SU1016314A1 (en) | 1979-12-17 | 1979-12-17 | Process for producing polyester urethanes |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1016314A1 (en) |
Cited By (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0593975A1 (en) * | 1992-10-19 | 1994-04-27 | Bayer Ag | Use of thermoplastic poly(ester-urethane) as a compostable plastic |
US5380813A (en) * | 1992-10-16 | 1995-01-10 | Neste Oy | Method for producing lactic acid based polyurethane |
WO1997040111A1 (en) * | 1996-04-18 | 1997-10-30 | Bayer Aktiengesellschaft | Compostable waterproof coating |
US6372876B1 (en) | 1992-07-29 | 2002-04-16 | Basf Aktiengesellschaft | Use of polyurethanes which are soluble or dispersible in water as aids in cosmetic and pharmaceutical compositions, and polyurethanes which contain polylactic acid polyols as copolymerized units |
US6503538B1 (en) | 2000-08-30 | 2003-01-07 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US7304122B2 (en) | 2001-08-30 | 2007-12-04 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US7648727B2 (en) | 2004-08-26 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Methods for manufacturing a coated stent-balloon assembly |
US7648725B2 (en) | 2002-12-12 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US7682669B1 (en) | 2001-07-30 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device |
US7691401B2 (en) | 2000-09-28 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Poly(butylmethacrylate) and rapamycin coated stent |
US7699889B2 (en) | 2004-12-27 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) block copolymers |
US7713637B2 (en) | 2006-03-03 | 2010-05-11 | Advanced Cardiovascular Systems, Inc. | Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US7749263B2 (en) | 2004-10-29 | 2010-07-06 | Abbott Cardiovascular Systems Inc. | Poly(ester amide) filler blends for modulation of coating properties |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US7766884B2 (en) | 2004-08-31 | 2010-08-03 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US7772359B2 (en) | 2003-12-19 | 2010-08-10 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US7776926B1 (en) | 2002-12-11 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for implantable medical devices |
US7775178B2 (en) | 2006-05-26 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Stent coating apparatus and method |
US7785512B1 (en) | 2003-07-31 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices |
US7785647B2 (en) | 2005-07-25 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Methods of providing antioxidants to a drug containing product |
US7795467B1 (en) | 2005-04-26 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable, biobeneficial polyurethanes for use in medical devices |
US7794743B2 (en) | 2002-06-21 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of making the same |
US7803394B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide hydrogel coatings for cardiovascular therapy |
US7803406B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US7807210B1 (en) | 2000-10-31 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Hemocompatible polymers on hydrophobic porous polymers |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
US7976891B1 (en) | 2005-12-16 | 2011-07-12 | Advanced Cardiovascular Systems, Inc. | Abluminal stent coating apparatus and method of using focused acoustic energy |
US7985440B2 (en) | 2001-06-27 | 2011-07-26 | Advanced Cardiovascular Systems, Inc. | Method of using a mandrel to coat a stent |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8007775B2 (en) | 2004-12-30 | 2011-08-30 | Advanced Cardiovascular Systems, Inc. | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US8017140B2 (en) | 2004-06-29 | 2011-09-13 | Advanced Cardiovascular System, Inc. | Drug-delivery stent formulations for restenosis and vulnerable plaque |
US8021676B2 (en) | 2005-07-08 | 2011-09-20 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
US8029816B2 (en) | 2006-06-09 | 2011-10-04 | Abbott Cardiovascular Systems Inc. | Medical device coated with a coating containing elastin pentapeptide VGVPG |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US8052912B2 (en) | 2003-12-01 | 2011-11-08 | Advanced Cardiovascular Systems, Inc. | Temperature controlled crimping |
US8062350B2 (en) | 2006-06-14 | 2011-11-22 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US8067025B2 (en) | 2006-02-17 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Nitric oxide generating medical devices |
US8067023B2 (en) | 2002-06-21 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating plasma polymerized film layers and charged amino acids |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US8110211B2 (en) | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US8147769B1 (en) | 2007-05-16 | 2012-04-03 | Abbott Cardiovascular Systems Inc. | Stent and delivery system with reduced chemical degradation |
US8173199B2 (en) | 2002-03-27 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US8192752B2 (en) | 2003-11-21 | 2012-06-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same |
US8197879B2 (en) | 2003-09-30 | 2012-06-12 | Advanced Cardiovascular Systems, Inc. | Method for selectively coating surfaces of a stent |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
US8303651B1 (en) | 2001-09-07 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric coating for reducing the rate of release of a therapeutic substance from a stent |
US8304012B2 (en) | 2006-05-04 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Method for drying a stent |
US8357391B2 (en) | 2004-07-30 | 2013-01-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8506617B1 (en) | 2002-06-21 | 2013-08-13 | Advanced Cardiovascular Systems, Inc. | Micronized peptide coated stent |
US8568764B2 (en) | 2006-05-31 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Methods of forming coating layers for medical devices utilizing flash vaporization |
US8586069B2 (en) | 2002-12-16 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US8597673B2 (en) | 2006-12-13 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Coating of fast absorption or dissolution |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8603634B2 (en) | 2004-10-27 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US8609123B2 (en) | 2004-11-29 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Derivatized poly(ester amide) as a biobeneficial coating |
US8647655B2 (en) | 2002-12-11 | 2014-02-11 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US8673334B2 (en) | 2003-05-08 | 2014-03-18 | Abbott Cardiovascular Systems Inc. | Stent coatings comprising hydrophilic additives |
US8685431B2 (en) | 2004-03-16 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same |
US8703169B1 (en) | 2006-08-15 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Implantable device having a coating comprising carrageenan and a biostable polymer |
US8703167B2 (en) | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US8778014B1 (en) | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
US8778375B2 (en) | 2005-04-29 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Amorphous poly(D,L-lactide) coating |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US9056155B1 (en) | 2007-05-29 | 2015-06-16 | Abbott Cardiovascular Systems Inc. | Coatings having an elastic primer layer |
US9102830B2 (en) | 2005-09-22 | 2015-08-11 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
US9114198B2 (en) | 2003-11-19 | 2015-08-25 | Advanced Cardiovascular Systems, Inc. | Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same |
US9339592B2 (en) | 2004-12-22 | 2016-05-17 | Abbott Cardiovascular Systems Inc. | Polymers of fluorinated monomers and hydrocarbon monomers |
US9375445B2 (en) | 2004-06-18 | 2016-06-28 | Abbott Cardiovascular Systems Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US9517203B2 (en) | 2000-08-30 | 2016-12-13 | Mediv As, Llc | Polymer particle delivery compositions and methods of use |
US9561351B2 (en) | 2006-05-31 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Drug delivery spiral coil construct |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US9580558B2 (en) | 2004-07-30 | 2017-02-28 | Abbott Cardiovascular Systems Inc. | Polymers containing siloxane monomers |
US10076591B2 (en) | 2010-03-31 | 2018-09-18 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
-
1979
- 1979-12-17 SU SU792854648A patent/SU1016314A1/en active
Non-Patent Citations (1)
Title |
---|
1. Губанов Э.Ф., Тейтельбаум Б.Я., Апухтина Н.П. и Синайский А.Г. Зависимость некоторых свойств полиэфируретановых блрксополимеров от молекул рного веса блоков. Синтез и изико-хими полимеров (полиуретаны) . К., Науковa Думка , 1968, с. 168. 2. Липатова Т.Э., Лоос С.С. и Момбужай М.М. Взаимодействие полиэфируретанов с физиологически активными средами. Высокомолекул рные соединени А 12. 1970, с. 20-51 (прототип) . * |
Cited By (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6372876B1 (en) | 1992-07-29 | 2002-04-16 | Basf Aktiengesellschaft | Use of polyurethanes which are soluble or dispersible in water as aids in cosmetic and pharmaceutical compositions, and polyurethanes which contain polylactic acid polyols as copolymerized units |
US5380813A (en) * | 1992-10-16 | 1995-01-10 | Neste Oy | Method for producing lactic acid based polyurethane |
EP0593975A1 (en) * | 1992-10-19 | 1994-04-27 | Bayer Ag | Use of thermoplastic poly(ester-urethane) as a compostable plastic |
WO1997040111A1 (en) * | 1996-04-18 | 1997-10-30 | Bayer Aktiengesellschaft | Compostable waterproof coating |
US7807211B2 (en) | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US7408018B2 (en) | 2000-08-30 | 2008-08-05 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US6503538B1 (en) | 2000-08-30 | 2003-01-07 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US9517203B2 (en) | 2000-08-30 | 2016-12-13 | Mediv As, Llc | Polymer particle delivery compositions and methods of use |
US7691401B2 (en) | 2000-09-28 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Poly(butylmethacrylate) and rapamycin coated stent |
US7807210B1 (en) | 2000-10-31 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Hemocompatible polymers on hydrophobic porous polymers |
US10064982B2 (en) | 2001-06-27 | 2018-09-04 | Abbott Cardiovascular Systems Inc. | PDLLA stent coating |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US7985440B2 (en) | 2001-06-27 | 2011-07-26 | Advanced Cardiovascular Systems, Inc. | Method of using a mandrel to coat a stent |
US7682669B1 (en) | 2001-07-30 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device |
US7304122B2 (en) | 2001-08-30 | 2007-12-04 | Cornell Research Foundation, Inc. | Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
US8303651B1 (en) | 2001-09-07 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric coating for reducing the rate of release of a therapeutic substance from a stent |
US8961588B2 (en) | 2002-03-27 | 2015-02-24 | Advanced Cardiovascular Systems, Inc. | Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin |
US8173199B2 (en) | 2002-03-27 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US7794743B2 (en) | 2002-06-21 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of making the same |
US7803406B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US7901703B2 (en) | 2002-06-21 | 2011-03-08 | Advanced Cardiovascular Systems, Inc. | Polycationic peptides for cardiovascular therapy |
US7875286B2 (en) | 2002-06-21 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide coatings and methods of coating implantable medical devices |
US8506617B1 (en) | 2002-06-21 | 2013-08-13 | Advanced Cardiovascular Systems, Inc. | Micronized peptide coated stent |
US8067023B2 (en) | 2002-06-21 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Implantable medical devices incorporating plasma polymerized film layers and charged amino acids |
US9084671B2 (en) | 2002-06-21 | 2015-07-21 | Advanced Cardiovascular Systems, Inc. | Methods of forming a micronized peptide coated stent |
US7803394B2 (en) | 2002-06-21 | 2010-09-28 | Advanced Cardiovascular Systems, Inc. | Polycationic peptide hydrogel coatings for cardiovascular therapy |
US8871883B2 (en) | 2002-12-11 | 2014-10-28 | Abbott Cardiovascular Systems Inc. | Biocompatible coating for implantable medical devices |
US8986726B2 (en) | 2002-12-11 | 2015-03-24 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US8871236B2 (en) | 2002-12-11 | 2014-10-28 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US7776926B1 (en) | 2002-12-11 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Biocompatible coating for implantable medical devices |
US8647655B2 (en) | 2002-12-11 | 2014-02-11 | Abbott Cardiovascular Systems Inc. | Biocompatible polyacrylate compositions for medical applications |
US7648725B2 (en) | 2002-12-12 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US8435550B2 (en) | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8586069B2 (en) | 2002-12-16 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders |
US9175162B2 (en) | 2003-05-08 | 2015-11-03 | Advanced Cardiovascular Systems, Inc. | Methods for forming stent coatings comprising hydrophilic additives |
US8673334B2 (en) | 2003-05-08 | 2014-03-18 | Abbott Cardiovascular Systems Inc. | Stent coatings comprising hydrophilic additives |
US7785512B1 (en) | 2003-07-31 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Method and system of controlled temperature mixing and molding of polymers with active agents for implantable medical devices |
US8197879B2 (en) | 2003-09-30 | 2012-06-12 | Advanced Cardiovascular Systems, Inc. | Method for selectively coating surfaces of a stent |
US9114198B2 (en) | 2003-11-19 | 2015-08-25 | Advanced Cardiovascular Systems, Inc. | Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same |
US8192752B2 (en) | 2003-11-21 | 2012-06-05 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same |
USRE45744E1 (en) | 2003-12-01 | 2015-10-13 | Abbott Cardiovascular Systems Inc. | Temperature controlled crimping |
US8052912B2 (en) | 2003-12-01 | 2011-11-08 | Advanced Cardiovascular Systems, Inc. | Temperature controlled crimping |
US7772359B2 (en) | 2003-12-19 | 2010-08-10 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US7786249B2 (en) | 2003-12-19 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Biobeneficial polyamide/polyethylene glycol polymers for use with drug eluting stents |
US8685431B2 (en) | 2004-03-16 | 2014-04-01 | Advanced Cardiovascular Systems, Inc. | Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same |
US8778014B1 (en) | 2004-03-31 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Coatings for preventing balloon damage to polymer coated stents |
US7820732B2 (en) | 2004-04-30 | 2010-10-26 | Advanced Cardiovascular Systems, Inc. | Methods for modulating thermal and mechanical properties of coatings on implantable devices |
US9101697B2 (en) | 2004-04-30 | 2015-08-11 | Abbott Cardiovascular Systems Inc. | Hyaluronic acid based copolymers |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US9375445B2 (en) | 2004-06-18 | 2016-06-28 | Abbott Cardiovascular Systems Inc. | Heparin prodrugs and drug delivery stents formed therefrom |
US8017140B2 (en) | 2004-06-29 | 2011-09-13 | Advanced Cardiovascular System, Inc. | Drug-delivery stent formulations for restenosis and vulnerable plaque |
US7758881B2 (en) | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8758801B2 (en) | 2004-07-30 | 2014-06-24 | Abbott Cardiocascular Systems Inc. | Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages |
US8357391B2 (en) | 2004-07-30 | 2013-01-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable devices comprising poly (hydroxy-alkanoates) and diacid linkages |
US9580558B2 (en) | 2004-07-30 | 2017-02-28 | Abbott Cardiovascular Systems Inc. | Polymers containing siloxane monomers |
US8586075B2 (en) | 2004-07-30 | 2013-11-19 | Abbott Cardiovascular Systems Inc. | Coatings for implantable devices comprising poly(hydroxy-alkanoates) and diacid linkages |
US7648727B2 (en) | 2004-08-26 | 2010-01-19 | Advanced Cardiovascular Systems, Inc. | Methods for manufacturing a coated stent-balloon assembly |
US7766884B2 (en) | 2004-08-31 | 2010-08-03 | Advanced Cardiovascular Systems, Inc. | Polymers of fluorinated monomers and hydrophilic monomers |
US8110211B2 (en) | 2004-09-22 | 2012-02-07 | Advanced Cardiovascular Systems, Inc. | Medicated coatings for implantable medical devices including polyacrylates |
US9067000B2 (en) | 2004-10-27 | 2015-06-30 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US8603634B2 (en) | 2004-10-27 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | End-capped poly(ester amide) copolymers |
US7749263B2 (en) | 2004-10-29 | 2010-07-06 | Abbott Cardiovascular Systems Inc. | Poly(ester amide) filler blends for modulation of coating properties |
US8609123B2 (en) | 2004-11-29 | 2013-12-17 | Advanced Cardiovascular Systems, Inc. | Derivatized poly(ester amide) as a biobeneficial coating |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
US9339592B2 (en) | 2004-12-22 | 2016-05-17 | Abbott Cardiovascular Systems Inc. | Polymers of fluorinated monomers and hydrocarbon monomers |
US7699889B2 (en) | 2004-12-27 | 2010-04-20 | Advanced Cardiovascular Systems, Inc. | Poly(ester amide) block copolymers |
US8007775B2 (en) | 2004-12-30 | 2011-08-30 | Advanced Cardiovascular Systems, Inc. | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
US7795467B1 (en) | 2005-04-26 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable, biobeneficial polyurethanes for use in medical devices |
US8778375B2 (en) | 2005-04-29 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Amorphous poly(D,L-lactide) coating |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US8021676B2 (en) | 2005-07-08 | 2011-09-20 | Advanced Cardiovascular Systems, Inc. | Functionalized chemically inert polymers for coatings |
US7785647B2 (en) | 2005-07-25 | 2010-08-31 | Advanced Cardiovascular Systems, Inc. | Methods of providing antioxidants to a drug containing product |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US8652504B2 (en) | 2005-09-22 | 2014-02-18 | Medivas, Llc | Solid polymer delivery compositions and methods for use thereof |
US9102830B2 (en) | 2005-09-22 | 2015-08-11 | Medivas, Llc | Bis-(α-amino)-diol-diester-containing poly (ester amide) and poly (ester urethane) compositions and methods of use |
US7976891B1 (en) | 2005-12-16 | 2011-07-12 | Advanced Cardiovascular Systems, Inc. | Abluminal stent coating apparatus and method of using focused acoustic energy |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US8067025B2 (en) | 2006-02-17 | 2011-11-29 | Advanced Cardiovascular Systems, Inc. | Nitric oxide generating medical devices |
US7713637B2 (en) | 2006-03-03 | 2010-05-11 | Advanced Cardiovascular Systems, Inc. | Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer |
US8596215B2 (en) | 2006-05-04 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8741379B2 (en) | 2006-05-04 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US8304012B2 (en) | 2006-05-04 | 2012-11-06 | Advanced Cardiovascular Systems, Inc. | Method for drying a stent |
US8465789B2 (en) | 2006-05-04 | 2013-06-18 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8637110B2 (en) | 2006-05-04 | 2014-01-28 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US7775178B2 (en) | 2006-05-26 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Stent coating apparatus and method |
US8568764B2 (en) | 2006-05-31 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Methods of forming coating layers for medical devices utilizing flash vaporization |
US9561351B2 (en) | 2006-05-31 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Drug delivery spiral coil construct |
US8703167B2 (en) | 2006-06-05 | 2014-04-22 | Advanced Cardiovascular Systems, Inc. | Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug |
US8778376B2 (en) | 2006-06-09 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating |
US8029816B2 (en) | 2006-06-09 | 2011-10-04 | Abbott Cardiovascular Systems Inc. | Medical device coated with a coating containing elastin pentapeptide VGVPG |
US8062350B2 (en) | 2006-06-14 | 2011-11-22 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US8808342B2 (en) | 2006-06-14 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8118863B2 (en) | 2006-06-14 | 2012-02-21 | Abbott Cardiovascular Systems Inc. | RGD peptide attached to bioabsorbable stents |
US8114150B2 (en) | 2006-06-14 | 2012-02-14 | Advanced Cardiovascular Systems, Inc. | RGD peptide attached to bioabsorbable stents |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US8592036B2 (en) | 2006-06-23 | 2013-11-26 | Abbott Cardiovascular Systems Inc. | Nanoshells on polymers |
US8293367B2 (en) | 2006-06-23 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Nanoshells on polymers |
US9028859B2 (en) | 2006-07-07 | 2015-05-12 | Advanced Cardiovascular Systems, Inc. | Phase-separated block copolymer coatings for implantable medical devices |
US8703169B1 (en) | 2006-08-15 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Implantable device having a coating comprising carrageenan and a biostable polymer |
US8597673B2 (en) | 2006-12-13 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Coating of fast absorption or dissolution |
US8147769B1 (en) | 2007-05-16 | 2012-04-03 | Abbott Cardiovascular Systems Inc. | Stent and delivery system with reduced chemical degradation |
US9056155B1 (en) | 2007-05-29 | 2015-06-16 | Abbott Cardiovascular Systems Inc. | Coatings having an elastic primer layer |
US8109904B1 (en) | 2007-06-25 | 2012-02-07 | Abbott Cardiovascular Systems Inc. | Drug delivery medical devices |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US10076591B2 (en) | 2010-03-31 | 2018-09-18 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1016314A1 (en) | Process for producing polyester urethanes | |
KR101952941B1 (en) | Polyester resin and preparation method of the same | |
KR101969004B1 (en) | Polyester resin and preparation method of the same | |
US8063169B2 (en) | Preparation of polyamide block copolymers | |
CA2449034A1 (en) | Copolyesters and polymerization of macrocyclic oligoesters | |
EP1056795B1 (en) | Compositions based on 2-methyl-1,3-propanediol and a phthalic acid | |
WO2000011063A1 (en) | A polyester resin and a process for preparing the same | |
JP2003507545A5 (en) | ||
US10227446B2 (en) | Method of producing glycolic acid polymers | |
US4182842A (en) | Poly(ester-amides)prepared from an aromatic dicarboxylic acid, ethylene glycol and a p-acylaminobenzoic acid | |
EP0375960B1 (en) | Thermoplastic, liquid-crystalline, wholly aromatic polyimide ester and method of producing the same | |
US6602963B2 (en) | Polyesters containing (meth)acrylate end groups | |
CA2423828A1 (en) | Polyester resins based on terephthalic acid and 2-methyl-1,3-propanediol and processes for the preparation thereof | |
EP1585779B1 (en) | Catalyst complex for catalysing esterification and trans-esterification reactions and process for esterification /trans-esterification using the same | |
WO1994021708A1 (en) | Aliphatic polyester and process for producing the same | |
Kricheldorf et al. | Thermoplastic elastomers 1. Poly (ether-ester-imide) s based on 1, 4-diaminobutane, trimellitic anhydride, 1, 4-dihydroxybutane and poly (tetramethylene oxide) diols | |
KR101514786B1 (en) | Polyester resin including component from biomass and preparation method of the same | |
KR101551930B1 (en) | Preparation method of polyester resin including component from biomass | |
US5298591A (en) | Non-crystalline wholly aromatic polyesters | |
JPH0753695A (en) | Production of polyester carbonate | |
US5070176A (en) | Melt phase polyarylate process | |
JPH0931176A (en) | Production of biodegradable aliphatic polyester | |
JPH06192374A (en) | Production of biodegradable polyester | |
JP3046658B2 (en) | Method for producing polyester containing urethane bond | |
JP2000026589A (en) | Production of polyhydroxycarboxylic acid |